Guardant Health
GH
#1154
Rank
A$29.30 B
Marketcap
A$216.62
Share price
1.30%
Change (1 day)
47.54%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report